Skip to main content
SpringerLink
Log in

Colorectal Cancer

  • Reference work entry
  • First Online:
Geriatric Diseases

  • 1604 Accesses

Abstract

The cause of colorectal cancer is not understood and appears to involve interactions between inherited susceptibility and environmental factors. Environmental factors play an important role and can increase the risk of colon cancer. The symptoms of colorectal cancer are similar to that of many other bowel disorders, but early colon cancer is asymptomatic. The risk of developing colorectal cancer rises sharply after the age of 40 years. A person under 40 years with positive family history should be investigated. It is appropriate to perform one or all the following in the order to make a firm diagnosis.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 379.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 379.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Australian Institute of Health and Welfare (AIHW) and Australasian Association of Cancer Registers, 2004. Cancer in Australia 2001. AIHW. Cat No CAN 23. AIHW Canberra.

    Google Scholar 

  2. Australian Bureau of Statistics, 2006. Causes of Death, Australia, 2004. cat.no 3303.0. ABS Canberra.

    Google Scholar 

  3. Baquet CR, Commiskey P. Colorectal cancer epidemiology in minorities: a review. J Assoc Acad Minor Phys. 1999;10(3):51–8.

    CAS  PubMed  Google Scholar 

  4. Sharma S, O’Keefe SJ. Environmental influences on the high mortality from colorectal cancer in African Americans. Postgrad Med J. 2007;83(983):583–9 .

    Article  PubMed  PubMed Central  Google Scholar 

  5. Lieberman D. Screening/early detection model for colorectal cancer. Why screen. Cancer. 1994;74 (7 Suppl):2023–7.

    Article  CAS  PubMed  Google Scholar 

  6. Cappell MS. From colonic polyps to colon cancer: pathophysiology clinical presentation screening and colonoscopic therapy. Minerva Gastroenterol Dietol. 2007;53(4):351–73.

    CAS  PubMed  Google Scholar 

  7. De Leon PM, Percesepe A. Pathogenesis of colorectal cancer Dig Liver Dis. 2000;32(9):807–821

    Article  Google Scholar 

  8. Bardhan K, Liu K. Epigenetics and colorectal cancer pathogenesis. Cancers (Basel). 2013;(2):676–713.

    Google Scholar 

  9. Coppede F. Epigenetic biomarkers of colorectal cancer: Focus on DNA methylation. Cancer Lett. 2014;342(2):238–47.

    Article  CAS  PubMed  Google Scholar 

  10. Grady WM, Markowitz SD. The molecular pathogenesis of colorectal cancer and its potential application to colorectal cancer screening. Dig Dis Sci.2014;60(3):762–772.

    Article  PubMed  PubMed Central  Google Scholar 

  11. Australian Institute of Health and Welfare (AIHW), 2002. Chronic diseases and associated risk factors in Australia, 2001, Canberra AIHW.

    Google Scholar 

  12. Burt RW. Familial risk and colorectal cancer. Gastroenterol Clin North Am. 1996;25(4):793–803.

    Article  CAS  PubMed  Google Scholar 

  13. Tejpar S. Risk stratification for colorectal cancer and implications for screening. Acta Gastroenterol Belg. 2005;68(2):241–2.

    CAS  PubMed  Google Scholar 

  14. Burt RW. Screening of patients with a positive family history of colorectal cancer. Gastrointest Endosc Clin. N Am 1997;7(1):65–79.

    CAS  PubMed  Google Scholar 

  15. NHMRC Guidelines for the prevention, early detection and management, A guide for general practitioners. ISBN. 1864960914. Cat No. 9925182.,

    Google Scholar 

  16. Atkin W. Options for screening for colorectal cancer. Scand J Gastroenterol. Suppl 2003;(237):13–6.

    Article  Google Scholar 

  17. Whitlock EP, Lin J, Liles E, Bell T, Fu R, O’Connor E, et al. Screening for colorectal cancer: An updated systematic review. Agency for Healthcare Research and Quality (US);2008 Oct. Report :08-05-05124-EF-1.

    Google Scholar 

  18. Sun L, Wu H, Guan Y. Colonography by CT, MRI, PET/CT combined with conventional colonoscopy in colorectal cancer screening and staging. World J Gastroenerol. 2008;14:853–63.

    Article  CAS  Google Scholar 

  19. Scholefeld JH, Moss S, Sufi F, Mangham CM. Hardcastle JD, et al. Effect of faecal occult blood screening for mortality from colorectal cancer: results from a randomized controlled trial. Gut. 2002;50:840–4.

    Article  Google Scholar 

  20. Jorgensen OD, Kronborg O, Finger CA. A randomized study of screening for colorectal cancer using Faecal Occult Blood Test: after 13 years and seven biennial screening rounds. Gut. 1002;50(1): 29–32.

    Google Scholar 

  21. Quintero E. Chemical or immunological tests for the detection of fecal occult blood in colorectal cancer screening? Gastroenterol Hepatol. 2009;32(8):565–76.

    Article  PubMed  Google Scholar 

  22. Traverso G, Shuber A, Levin B, Johnson C, Olsson L, Schoetz DJ, et al. Detection of APC mutations in faecal DNA from patients with colorectal tumours. N Eng J Med. 2002;346:311–20.

    Article  CAS  Google Scholar 

  23. Davies H, Bignell GR, Cox C, Stephens P, Edkins S, Clegg S, et al. Mutations of the BRAF gene in human cancer. Nature. 2002;417:949–54.

    Article  CAS  PubMed  Google Scholar 

  24. Kimura K, Nagasaka T, Hosnizima N. No duplicate KRAS mutation is identified on the same allele in gastric or colorectal cancer cells with multiple KRAS mutations. J Int Med Res. 2007;35:450–7.

    Article  CAS  PubMed  Google Scholar 

  25. Deenadayalu VP, Rex DK. Fecal-based DNA assays: a new non-invasive approach to colorectal screening. Cleveland Clin FJ Med. 2004;71:497–503.

    Article  Google Scholar 

  26. Muller HM, Oberwalder M, Fiegl H, Morandell M, Goebel G, Zitt M, et al. Methylation changes in faecal DNA: a marker for colorectal screening. Lancet. 2004; 262:1283–5.

    Article  Google Scholar 

  27. Cancer Research UK. Statistics and outlook for bowel cancer. http://www.cancerresearchuk.org/about-cancer/type/bowel-cancer/treatment/statistics… accessed 15 February 2015.

  28. Dunn J, Lynch, Rinaldis M, Pakenham K, McPherson L, Owe N, et al. Dimension of quality of life and psychological variables most salient to colorectal patients. Psychooncology. 2006;15(1):20–30.

    Article  PubMed  Google Scholar 

  29. Cotrum H, Pereira G. Impact of colorectal cancer on patient and family; implications for care. Eur J Oncol Nurs. 2008;12(3):217–26.

    Article  Google Scholar 

  30. Avery JC, Nishimoto PW. Psychosocial issues in colorectal cancer survivorship: top ten questions may not be asking. J Gastrointestinal Oncol. 2014;5(5):395–400. https://doi.org/10.3978/j.issn.2078-6891.2014.058.

  31. Ceillenchair AO, Costello L, Finn C, Timmons A, Fitzpatrick P, Kapr K, et al. Inter-relationship between economic and emotional consequences of colorectal cancer for patients and their families: a qualitative study. BMC Gastroenterology. 2012;12:62. doi.10.3.3978/.issn.2078-68912014.058.

    Google Scholar 

  32. Ceillencair AO, Hanly P, Skally M, O’Neill C, Sharp L. The economic impact of colorectal cancer: What are the costs and where do they fall ? NCIN:Cancer Outcome Conference 2012;14–15June 2012. Hilton, Birmngham. Metropole, Birmingham.

    Google Scholar 

  33. Meester RGS, Donbem CA, Zanber AG, Goide SL, Levin TR, Corley DA, et al. Public health impact of achieving 80% colorectal cancer. Screening rates in the United States by 2018. Cancer. 2015;121:2281–2285.

    Article  PubMed  PubMed Central  Google Scholar 

  34. Ananda SS, McLaughln SJ, Chen F, Hayes IP, Hunter AA, Skinner IJ, et al. Initial impact of Australian National Bowel Cancer Screening Program. Med J Aust. 2009;191(7):378–381.

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. The University of Sydney, Westmead Clinical School, Westmead, NSW, Australia

    Nages Nagaratnam & Kujan Nagaratnam

  2. Rehabilitation and Aged Care Service, Blacktown-Mt Druitt Hospital, Mount Druitt, NSW, Australia

    Gary Cheuk

Authors
  1. Nages Nagaratnam
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Kujan Nagaratnam
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Gary Cheuk
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

Copyright information

© 2018 Springer International Publishing AG, part of Springer Nature

About this entry

Check for updates. Verify currency and authenticity via CrossMark

Cite this entry

Nagaratnam, N., Nagaratnam, K., Cheuk, G. (2018). Colorectal Cancer. In: Geriatric Diseases. Springer, Cham. https://doi.org/10.1007/978-3-319-33434-9_15

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-33434-9_15

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-33433-2

  • Online ISBN: 978-3-319-33434-9

  • eBook Packages: MedicineReference Module Medicine

Publish with us

Policies and ethics

Search

Navigation